Prime Medicine Inc (PRME)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 2,983 | 0 | 0 | 0 | 5,210 |
| Gross Profit | 2,983 | N/A | N/A | N/A | 5,210 |
| Operating Expenses | 205,450 | 204,792 | 116,544 | 84,474 | 6,142 |
| Operating Income | -202,467 | -204,792 | -116,544 | -84,474 | -932 |
| Other Income | 6,585 | 6,380 | -6,225 | -81,379 | -611 |
| Pre-tax Income | -195,882 | -198,412 | -122,769 | -165,853 | -1,543 |
| Income Tax | N/A | -279 | -948 | -486 | 1,867 |
| Net Income Continuous | -195,882 | -198,133 | -121,821 | -165,367 | -3,410 |
| Net Income | $-195,882 | $-198,133 | $-121,821 | $-165,367 | $-3,410 |
| EPS Basic Total Ops | -1.65 | -2.18 | -4.19 | -14.19 | -1.91 |
| EPS Basic Continuous Ops | -1.65 | -2.18 | -3.59 | -12.75 | -1.29 |
| EPS Diluted Total Ops | -1.65 | -2.18 | -4.19 | -14.19 | -1.91 |
| EPS Diluted Continuous Ops | -1.65 | -2.18 | -3.59 | -12.75 | -1.29 |
| EPS Diluted Before Non-Recurring Items | -1.65 | -2.03 | -4.19 | N/A | N/A |
| EBITDA(a) | $-199,433 | $-203,547 | $-114,570 | $-83,191 | $-889 |